Carbapenemase-producing <i>Enterobacterales</i> infections in COVID-19 patients
Vicente Pintado, Patricia Ruíz-Garbajosa, Rosa Escudero-Sánchez, Francesca Gioia, Sabina Herrera, Pilar Vizcarra, Jesús Fortün, Javier Cobo, Pilar Martín‐Dávila, María Isabel Morosini, Rafael Cantón, Santiago Moreno
Abstract
BACKGROUND: (CPE) infections have been occasionally described in patients with coronavirus disease-19 (COVID-19). We assess the clinical features and outcome of these infections. METHODS: In this retrospective single-centre, case-control study, we included 54 patients with CPE infection: 30 case-patients (COVID-19) and 24 controls (non-COVID-19), collected between March and May 2020. We compared the epidemiological, clinical features, and outcome between cases and controls. RESULTS: = .25). CONCLUSIONS: COVID-19 patients have an increased risk of CPE infections, which usually present as severe, nosocomial infections, appearing in critically-ill patients and associated with a high mortality.